| Literature DB >> 35821782 |
Thanh-Thin Vo1, Van-Tuan Dang1, Dinh-Hai Le1, Trong-Hai Nguyen1,2.
Abstract
Background: Septicemia caused by Riemerella anatipestifer (R. anatipestifer) is a serious problem in the duck industry worldwide, and it is currently one of the major concerns for duck farming in Vietnam.. Aim: This study was conducted to identify the causative agent of septicemia in ducks in Vietnam. The antimicrobial susceptibility and serotypes of R. anatipestifer isolates were also determined to provide valuable information for disease treatment and vaccine development.Entities:
Keywords: Antimicrobial susceptibility; Ducks; R. anatipestifer; Serotyping
Mesh:
Substances:
Year: 2022 PMID: 35821782 PMCID: PMC9270934 DOI: 10.5455/OVJ.2022.v12.i3.13
Source DB: PubMed Journal: Open Vet J ISSN: 2218-6050
Fig. 1.Locations of the four provinces (shaded) in Vietnam where samples were collected (from the North to the South: Thai Binh, Thanh Hoa, Binh Dinh, and Long An).
Fig. 2.Colonies of R. anatipestifer on the blood agar.
Fig. 3.Colonies of R. anatipestifer on the chocolate agar.
Fig. 4.Gram stain of R. anatipestifer (1,000×).
Fig. 5.PCR amplicons (662 bp) of 16s rRNA gene of R. anatipestifer. Lane 1: DNA marker 100 bp; lane 2: negative control; lane 3: positive control; and lane 4–7: R. anatipestifer isolates.
Fig. 6.Phylogenetic relationship between R. anatipestifer isolates, R. anatipestifer reference strain, P. gallinarum, and O. rhinotracheale based on the partial sequences of 16s rRNA gene.
Serotyping of R. anatipestifer isolates.
| Number of tested isolates | Serotype | Positive isolates | Percentage |
|---|---|---|---|
| 69 | 1 | 3 | 4.3 |
| 69 | 6 | 1 | 1.4 |
| 69 | 8 | 2 | 2.9 |
| 69 | 10 | 22 | 31.9 |
| 69 | 20 | 2 | 2.9 |
| 69 | Ns | 39 | 56.5 |
(Ns): Nonserotypable.
The susceptibility of R. anatipestifer isolates to commonly used antibiotics.
| Antibiotics | Number of tested isolates | Resistance | Intermediate | Susceptible | |||
|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | ||
| Amoxicillin/clavulanic acid | 69 | 0 | 0.0 | 0 | 0.0 | 69 | 100.0 |
| Imipenem | 69 | 0 | 0.0 | 0 | 0.0 | 69 | 100.0 |
| Florfenicol | 69 | 6 | 8.6 | 0 | 0.0 | 63 | 91.3 |
| Cefoperazone | 69 | 0 | 0.0 | 7 | 10.1 | 62 | 89.9 |
| Piperacillin | 69 | 5 | 7.2 | 2 | 2.9 | 62 | 89.9 |
| Ceftazidime | 69 | 5 | 7.2 | 2 | 2.9 | 62 | 89.9 |
| Cefepime | 69 | 7 | 10.1 | 2 | 2.9 | 60 | 87.0 |
| Cephalecin | 69 | 2 | 2.9 | 7 | 10.1 | 60 | 87.0 |
| Doxycycline | 69 | 4 | 5.8 | 5 | 7.2 | 60 | 87.0 |
| Cephalothin | 69 | 11 | 15.9 | 4 | 5.8 | 54 | 78.3 |
| Ceftriaxone | 69 | 4 | 5.8 | 15 | 21.7 | 50 | 72.5 |
| Ofloxacin | 69 | 11 | 15.9 | 8 | 11.6 | 50 | 72.5 |
| Amikacin | 69 | 17 | 24.6 | 4 | 5.8 | 48 | 69.6 |
| Oxacilin | 69 | 30 | 43.5 | 4 | 5.8 | 35 | 50.7 |
| Gentamicin | 69 | 28 | 40.6 | 6 | 8.7 | 35 | 50.7 |
| Penicillin | 69 | 16 | 23.2 | 19 | 27.5 | 34 | 49.3 |
| Trimethoprime/sulfamethoxazol | 69 | 24 | 34.8 | 13 | 18.8 | 32 | 46.4 |
| Neomicin | 69 | 24 | 34.8 | 15 | 21.7 | 30 | 43.5 |
| Tetracycline | 69 | 13 | 18.8 | 34 | 49.3 | 22 | 31.9 |
| Ciprofloxacin | 69 | 13 | 18.8 | 37 | 53.7 | 19 | 27.5 |
| Streptomycin | 69 | 52 | 75.4 | 2 | 2.9 | 15 | 21.7 |
| Kanamycin | 69 | 45 | 65.2 | 11 | 15.9 | 13 | 18.9 |
| Erythromycin | 69 | 17 | 24.6 | 45 | 65.3 | 7 | 10.1 |
| Norfloxacin | 69 | 50 | 72.5 | 15 | 21.7 | 4 | 5.8 |
| Nalidixic acid | 69 | 62 | 89.9 | 5 | 7.2 | 2 | 2.9 |